Cogent Biosciences, Inc. (COGT)
37.16
+0.79
(+2.17%)
USD |
NASDAQ |
Apr 13, 10:22
Cogent Biosciences Shareholders Equity (Quarterly) : 636.37M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Syndax Pharmaceuticals, Inc. | 64.63M |
| Vera Therapeutics, Inc. | 604.52M |
| Terns Pharmaceuticals, Inc. | 1.007B |
| Nuvalent, Inc. | 1.248B |
| Insmed, Inc. | 738.98M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 937.61M |
| Total Liabilities (Quarterly) | 301.24M |
| Debt to Equity Ratio | 0.3752 |
| Current Ratio | 14.23 |
| Net Debt Paydown Yield | -0.77% |